CompaniesAulos Bioscience
Aulos Bioscience logo

Aulos Bioscience

active
Larkspur, CA, United States
Founded 2020
Website
About

IL-2 binding monoclonal antibodies

Areas of Focus

Categories

Biologics & BiopharmaceuticalAntibodyBiotech
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

159

By Phase

PHASE1/PHASE2: 1

By Status

RECRUITING: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2021
2022
2023
2024
2025
2026
2027
Today
NCT05267626
Hover over trial bars to see details

Recent Trials

NCT05267626Lead Sponsor
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
PHASE1/PHASE2Recruiting
159 participants
Started: Apr 4, 2022 · Completed: Jun 12, 2026
Funding History (2)
D
Aug 10, 2023
Filing
D
Nov 16, 2020
Filing
Locations (1)
Headquarters
Larkspur, CA, United States
Map

Loading map...